International Myeloma Foundation: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
== International Myeloma Foundation == | |||
[[File:IMF_logo2018.jpg|thumb|right|Logo of the International Myeloma Foundation]] | |||
The '''International Myeloma Foundation''' (IMF) is a non-profit organization dedicated to improving the quality of life of [[multiple myeloma]] patients while working toward prevention and a cure. Founded in 1990, the IMF is the oldest and largest myeloma-specific foundation in the world. | |||
The | |||
== | == Mission and Goals == | ||
The mission of the International Myeloma Foundation is to improve the quality of life of myeloma patients while working toward prevention and a cure. The IMF focuses on four key areas: research, education, support, and advocacy. | |||
== | === Research === | ||
[[Category: | The IMF supports [[clinical trials]] and research initiatives aimed at understanding the biology of multiple myeloma and developing new [[therapies]]. The foundation funds innovative research projects and collaborates with leading scientists and institutions worldwide. | ||
[[Category: | |||
=== Education === | |||
The IMF provides educational resources for patients, caregivers, and healthcare professionals. These resources include publications, seminars, and online tools designed to increase awareness and understanding of multiple myeloma. | |||
=== Support === | |||
Support services offered by the IMF include a toll-free hotline, support groups, and online forums where patients and caregivers can connect and share experiences. The foundation also provides guidance on managing the disease and its treatment. | |||
=== Advocacy === | |||
The IMF advocates for policies that improve access to care and treatment for myeloma patients. The foundation works with government agencies, healthcare providers, and other organizations to promote awareness and support for myeloma research and treatment. | |||
== History == | |||
The International Myeloma Foundation was established in 1990 by [[Brian G.M. Durie]], M.D., and [[Susie Novis Durie]]. Since its inception, the IMF has grown into a global organization with a presence in more than 140 countries. The foundation has played a pivotal role in advancing research and improving patient care for those affected by multiple myeloma. | |||
== Programs and Initiatives == | |||
The IMF offers a variety of programs and initiatives designed to support its mission. These include the International Myeloma Working Group (IMWG), the Black Swan Research Initiative, and the Myeloma Action Month campaign. | |||
=== International Myeloma Working Group === | |||
The International Myeloma Working Group (IMWG) is a consortium of leading myeloma experts from around the world. The IMWG conducts research, develops treatment guidelines, and publishes consensus statements to advance the understanding and treatment of multiple myeloma. | |||
=== Black Swan Research Initiative === | |||
The Black Swan Research Initiative is a groundbreaking research project aimed at finding a cure for multiple myeloma. The initiative focuses on identifying and eradicating minimal residual disease (MRD) in myeloma patients. | |||
=== Myeloma Action Month === | |||
Myeloma Action Month is an annual campaign held in March to raise awareness about multiple myeloma. The campaign encourages individuals and organizations to take action in support of myeloma patients and research. | |||
== Related Pages == | |||
* [[Multiple myeloma]] | |||
* [[Cancer research]] | |||
* [[Non-profit organization]] | |||
{{Medical organizations}} | |||
[[Category:Medical and health organizations]] | |||
[[Category:Non-profit organizations]] | |||
[[Category:Organizations established in 1990]] | |||
Latest revision as of 16:27, 16 February 2025
International Myeloma Foundation[edit]
The International Myeloma Foundation (IMF) is a non-profit organization dedicated to improving the quality of life of multiple myeloma patients while working toward prevention and a cure. Founded in 1990, the IMF is the oldest and largest myeloma-specific foundation in the world.
Mission and Goals[edit]
The mission of the International Myeloma Foundation is to improve the quality of life of myeloma patients while working toward prevention and a cure. The IMF focuses on four key areas: research, education, support, and advocacy.
Research[edit]
The IMF supports clinical trials and research initiatives aimed at understanding the biology of multiple myeloma and developing new therapies. The foundation funds innovative research projects and collaborates with leading scientists and institutions worldwide.
Education[edit]
The IMF provides educational resources for patients, caregivers, and healthcare professionals. These resources include publications, seminars, and online tools designed to increase awareness and understanding of multiple myeloma.
Support[edit]
Support services offered by the IMF include a toll-free hotline, support groups, and online forums where patients and caregivers can connect and share experiences. The foundation also provides guidance on managing the disease and its treatment.
Advocacy[edit]
The IMF advocates for policies that improve access to care and treatment for myeloma patients. The foundation works with government agencies, healthcare providers, and other organizations to promote awareness and support for myeloma research and treatment.
History[edit]
The International Myeloma Foundation was established in 1990 by Brian G.M. Durie, M.D., and Susie Novis Durie. Since its inception, the IMF has grown into a global organization with a presence in more than 140 countries. The foundation has played a pivotal role in advancing research and improving patient care for those affected by multiple myeloma.
Programs and Initiatives[edit]
The IMF offers a variety of programs and initiatives designed to support its mission. These include the International Myeloma Working Group (IMWG), the Black Swan Research Initiative, and the Myeloma Action Month campaign.
International Myeloma Working Group[edit]
The International Myeloma Working Group (IMWG) is a consortium of leading myeloma experts from around the world. The IMWG conducts research, develops treatment guidelines, and publishes consensus statements to advance the understanding and treatment of multiple myeloma.
Black Swan Research Initiative[edit]
The Black Swan Research Initiative is a groundbreaking research project aimed at finding a cure for multiple myeloma. The initiative focuses on identifying and eradicating minimal residual disease (MRD) in myeloma patients.
Myeloma Action Month[edit]
Myeloma Action Month is an annual campaign held in March to raise awareness about multiple myeloma. The campaign encourages individuals and organizations to take action in support of myeloma patients and research.